Lubner David Charles
Related Filers (9)
- TETRAPHASE PHARMACEUTICALS INC (13)
- Ra Pharmaceuticals, Inc. (6)
- POINT Biopharma Global Inc. (6)
- Dyne Therapeutics, Inc. (6)
- Gemini Therapeutics, Inc. /DE (6)
- Vor Biopharma Inc. (4)
- Arcellx, Inc. (4)
- Nightstar Therapeutics plc (3)
- CARGO Therapeutics, Inc. (2)
- Show More ...
Ownership (50)
4
Wednesday, 12/27/2023
POINT Biopharma Global Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/13/2023
CARGO Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 11/9/2023
CARGO Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/16/2023
Arcellx, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/5/2023
POINT Biopharma Global Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2023
Vor Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/25/2023
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/28/2022
POINT Biopharma Global Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/6/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Vor Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/6/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/6/2022
POINT Biopharma Global Inc.: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 3/9/2022
Gemini Therapeutics, Inc. /DE: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 3/9/2022
Gemini Therapeutics, Inc. /DE: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/9/2022
Arcellx, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/7/2022
Arcellx, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 2/3/2022
Arcellx, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 10/6/2021
Gemini Therapeutics, Inc. /DE: Statement of changes in beneficial ownership of securities
4
Thursday, 7/8/2021
POINT Biopharma Global Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/27/2021
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/7/2021
Gemini Therapeutics, Inc. /DE: Statement of changes in beneficial ownership of securities
4
Monday, 3/15/2021
Gemini Therapeutics, Inc. /DE: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/10/2021
Gemini Therapeutics, Inc. /DE: Initial statement of beneficial ownership of securities
4
Tuesday, 2/9/2021
Vor Biopharma Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 2/4/2021
Vor Biopharma Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 9/23/2020
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/16/2020
Dyne Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 7/7/2020
Therapeutics Acquisition Corp.: Initial statement of beneficial ownership of securities
4
Friday, 4/3/2020
Ra Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/7/2019
Nightstar Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/5/2019
Ra Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/29/2019
Nightstar Therapeutics plc: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/2/2019
Nightstar Therapeutics plc: Initial statement of beneficial ownership of securities
4
Monday, 2/5/2018
Ra Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/3/2017
Ra Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/31/2016
Ra Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/25/2016
Ra Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 8/17/2015
TETRAPHASE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/15/2015
TETRAPHASE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/16/2015
TETRAPHASE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 5/18/2015
TETRAPHASE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 1/9/2015
TETRAPHASE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/18/2014
TETRAPHASE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 3/10/2014
TETRAPHASE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 2/13/2014
TETRAPHASE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/11/2014
TETRAPHASE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 1/10/2014
TETRAPHASE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 5/17/2013
TETRAPHASE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/27/2013
TETRAPHASE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Tuesday, 3/19/2013
TETRAPHASE PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities